Publications

Publications2025-12-29T20:43:38+00:00

Latest Publications

Explore our most recent scientific milestones, peer-reviewed insights, and the impact Unicorn Biotechnologies is making in the life sciences space.

Alternatives to Knee Replacement for Elderly Patients: The Age-Specific Risk and Candidacy Framework That Addresses Every Concern — From Surgical Danger to Independence in 2026

For elderly patients facing a knee replacement recommendation, non-surgical and minimally invasive alternatives may offer meaningful relief without the elevated risks of surgery. This evidence-based guide maps regenerative therapies, injections, and conservative treatments to aging physiology. Discover the age-specific candidacy framework helping families make confident, informed decisions in 2026.

August 13th, 2026|Categories: Uncategorized|

What Causes Knee Pain in Females: The Female Biology Framework That Explains Why Your Hormones, Anatomy, and Life Stage Matter More Than Your X-Ray in 2026

Female knee pain is biologically distinct—driven by hormones, anatomy, and life stage, not just what an X-ray shows. This guide breaks down what causes knee pain in females across four key life stages, from adolescence through postmenopause. If your pain has been dismissed or unexplained, this framework changes everything.

August 13th, 2026|Categories: Uncategorized|

Achilles Tendon Injury Non Surgical Treatment: The Weekend Warrior’s Protocol Framework That Maps Every Conservative Option — From Functional Bracing to Biologics — Based on 35,896-Patient Evidence in 2026

Achilles tendon injury non surgical treatment has never been more evidence-based. This 2026 protocol framework maps every conservative option—from functional bracing to biologics—across a landmark 35,896-patient review. Whether you're facing a rupture or chronic tendinopathy, discover the tiered decision approach built for the weekend warrior.

August 13th, 2026|Categories: Uncategorized|

Stem Cells and Regenerative Medicine: The 2026 Patient’s Complete Field Guide — From FDA-Approved Therapies to Orthopedic Applications and How to Tell the Difference

Stem cells and regenerative medicine reached a turning point in 2026, with landmark FDA approvals, CRISPR-based cures, and a booming $48 billion market. But hundreds of unregulated clinics make it harder than ever for patients to separate proven therapies from predatory ones. This complete field guide gives you the framework to tell the difference and make informed decisions.

August 13th, 2026|Categories: Uncategorized|

Hip Labrum Tear Treatment Without Surgery: The Tear-Grade Decision Framework That Sets Honest Expectations — Including What the 2025 Meta-Analysis Found About Surgery vs. Conservative Care in 2026

Not every hip labral tear requires surgery — but honest expectations depend on the grade of your tear. This evidence-based guide breaks down which non-surgical treatments are appropriate for each tear grade and what the latest research reveals about conservative care outcomes in 2026.

August 13th, 2026|Categories: Uncategorized|

Regenerative Injection for Shoulder Impingement: The Corticosteroid-vs-Biologic Evidence Framework That Tells You Which Option Actually Wins Long-Term in 2026

Cortisone shots offer short-term relief for shoulder impingement, but the evidence is shifting. This 2026 clinical framework compares corticosteroids against regenerative injections—including PRP, prolotherapy, BMAC, and exosome therapy—using real trial outcomes. Find out which option delivers superior long-term results for shoulder impingement syndrome.

August 13th, 2026|Categories: Uncategorized|

Discover The Future

Committed to innovation and patient-centered solutions.

Go to Top